Stockreport

TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

TScan Therapeutics, Inc.  (TCRX) 
PDF WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell [Read more]